New Yorker essay shines a spotlight on the scourge of autoimmune disease

Utah 2013 aes  - 080

For autoimmune patients—and I’m one of them—life sometimes feels like a lonely uphill climb:

“getting sick for no good reason, falling prey to esoteric infections and mysterious skin outbreaks, sliding into spells of lethargy and exhaustion that looked so much like laziness it was maddening.”

Excerpt from A Stroke of Bad Luck and the Potholed Road to Recovery

In her essay “What’s Wrong With Me” published in this week’s New Yorker (Aug. 26, 2013), author Meghan O’Rourke shines a spotlight on what it’s like to live with autoimmune disease. Recounting experiences all too familiar to autoimmune patients, and to me, O’Rourke describes:

  • symptoms ranging from hives to migraines, buzzing in her throat, numbness in her feet;
  • terrible fatigue that made her feel like “a mechanism that moved arduously through the world, simply trying to complete its tasks. Sitting upright at my father’s birthday party required a huge act of will.”
  • her brain often “enveloped in a thick gray fog”
  • a susceptibility to viruses (in her case cytomegalovirus, parvovirus, and Epstein-Barr)
  • a family history sprinkled with various seemingly unrelated illnesses that (she learned later) are all autoimmune in nature.

 

Like many autoimmune patients, O’Rourke rattled from doctor to doctor for years before any of them believed she had a disease.  “Many clinicians assume that the patient, who is often a young woman, is just one of the ‘worried well,’” she writes. Finally, after six years, she had her diagnosis: autoimmune thyroiditis, often called Hashimoto’s, the same disease that plagued my grandmother.

I missed the the doctor-to-doctor crawl because I had no clue that my body was harboring any kind of illness until I was felled by a stroke caused by my particular autoimmune disease: antiphospholipid syndrome (APS).

O’Rourke writes movingly about what it’s like to struggle with a debilitating condition—autoimmunity—that no one, even specialists, understands well.

The lack of knowledge is shocking to me, considering the magnitude of the problem: The American Association of Autoimmune Related Diseases (AARDA) estimates that as many as fifty million Americans suffer from autoimmunity—a greater number than cancer.  

 

There are somewhere between eighty and one hundred autoimmune diseases, yet “autoimmune disease is as much of a medical frontier today as syphilis or tuberculosis was in the nineteenth century,” O’Rourke writes. “Some researchers say the number of cases is rising at almost epidemic rates.”

At times during the course of searching for a diagnosis and treatment of her illness O’Rourke questioned her own sanity:

  • “Was I going mad?” she asks.
  • “The worst part of my fatigue, the one I couldn’t explain to anyone—I knew I’d seem crazy—was the loss of an intact sense of self.”
  • “To be sick in this way is to have the unpleasant feeling that you are impersonating yourself.”

 

“It was a struggle,” she writes, “to do anything—to teach my class, to tidy the house, to go to the gym. My joints hurt, my neck hurt; I had nosebleeds and large bruises up and down my legs. I spend hours everyday unable to work …” This situation is all too familiar to me and other autoimmune patients.

Like many who suffer from autoimmunity, O’Rourke found information and solace in on-line support groups, “people, rich and poor, who were connected by one thing: the inability of doctors to alleviate their symptoms.”   She also turned to diet hoping to mediate her disease. She followed a diet similar to the so-called Paleo regimen: “no gluten, no refined sugar, little dairy” so strictly that, while it did ease some of her symptoms, she spent “at least half of each day” shopping for food, eating, and cleaning up.

“What I had wasn’t just an illness now; it was an identity, a membership in a peculiarly demanding sect. I had joined the First Assembly of the Diffusely Unwell …”

But O’Rourke realized that she didn’t want her life to be defined by illness.

Echoing the concern of many autoimmune patients, she writes: “I worried that I would no longer have friends.”

“The chronically ill patient has to hold in mind two contradictory modes: insistence on the reality of her disease, and resistance to her own catastrophic fears.” Amen to that.

CV1_TNY_08_26_13Drooker.inddO’Rourke’s thoughtful essay has much more to say about autoimmune disease and her experience.  Anyone concerned about the scourge of autoimmunity should read it.  If you’re not a New Yorker subscriber, you can find this issue at newsstands this week, or order a single copy from The New Yorker here.

10 Replies to “New Yorker essay shines a spotlight on the scourge of autoimmune disease”

  1. That is amazing. I suffer and have tried to regain my identity for the past three years with very little understanding and help from doctors. They don’t believe the pain is bad enough to stop you dead in your tracks .They don’t believe the fatigue is so bad that you could sleep your life away literally. With understanding of invisible symptoms and them not connecting the dots enough between patients they will never understand.
    We get diagnosed with anxiety problems, depression, and any other mental issues including addicts because they don’t understand.

    1. Have you been checked for Hashimoto’s?? I had to find a blood lab where I could order my own tests: you must have the thyroid antibody tests — the TSH is not a viable indicator of Hashimoto’s…..My doctors would have never ordered the tests…..Now I’m experimenting with a variety of thyroid meds…..Check with Hashimoto web sites — and specialists that are open to unconventional options…..Good Luck!

  2. Thank you for writing this! I am not a subscriber to the New Yorker and could not figure out how to order a copy of this issue – many thanks for the link!

    I have Hashimoto’s thyroid disease and when I bring it up nearly half of the women I know over 50 also have it. A book that really opened my eyes was “The Autoimmune Epidemic” by Donna Jackson Nakazawa. It truly IS an epidemic yet seems to get very little press.

    Hopefully just like TB, we will figure this one out!

  3. As to “the lack of knowledge” about autoimmune disease, AARDA has the statistics about funding:

    “NIH research funding for Autoimmune Disease in 2003 came to $591 million. In comparison, cancer funding came to $6.1 billion; and heart and stroke, to $2.4 billion (source: NIH)”

    Even though:

    NIH estimates up to 23.5 million Americans have an AD. In comparison, cancer affects up to 9 million and heart disease up to 22 million.

    NIH estimates annual direct health care costs for AD to be in the range of $100 billion (source: NIH presentation by Dr. Fauci, NIAID). In comparison, cancers costs are $57 billion (source: NIH,ACS), and heart and stroke costs are $200 billion (source: NIH, AHA).

    1. The 23.5 million with AD HAS been revised up to the 50 million you quoted! Not sure why they haven’t updated this estimate on this page

  4. Re the number of autoimmune disease sufferers: The number “as many as 50 million” comes from the American Autoimmune Related Diseases Association (AARDA). The NIH website stills has the 5-8 percent of the US population, which would be consistent with the 25 million. Perhaps NIH hasn’t caught up with AARDA?

  5. The reason there is a diference between the NIH figure and AARDA’s is the NIH figure is based on an epidemiolgy study that only included 24 of the autoimmune diseases for which there were good studies while AARDA’s includes over 80 autoimmune diseases. Most autoimune diseases do not have epidemiology studies.

  6. re: no funding for research
    I’m told there’s no funding because the Big Pharm companies don’t think it’s likely they could develop a high-cost drug to treat Hashimotos. So – not only do they not research it. Because there’s no drug for it, physicians don’t recognize it, or don’t recognize all the ways it’s debilitating. If there’s not a drug to fix it, the problem just must not exist – like others, I’ve found my best approaches through alternative practitioners, and a vigilant approach to what I eat, what I do, and what I expose myself to.

Leave a Reply

Your email address will not be published. Required fields are marked *